HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wide-field fusional stimulation in strabismus.

Abstract
The effectiveness of wide-field fusional stimulation was evaluated on 57 strabismics and 29 patients with convergence insufficiency. The strabismics had fusion, normal retinal correspondence (even if it coexisted with anomalous retinal correspondence), a deviation not exceeding 30 delta, and visual acuity of 6/7.5 or better. The strabismics included intermittent exotropes, surgically overcorrected intermittent exotropes, and accomodative esotropes. Of these strabismic patients, 42 responded to therapy in which tropias were converted to phorias or the frequency of the manifest deviation was significantly reduced, fusional amplitudes were significantly enlarged, and in many cases, stereoacuity improved as well. In 16 cases, surgery that was recommended before treatment is no longer being considered. Of the patients with convergence insufficiency, 23 responded to therapy which resulted in the enlargement of fusional amplitudes and the alleviation of symptoms. Follow-up visits (for up to 5 years) confirm that the improvement persists, which indicates the utility and effectiveness of this technique.
AuthorsA E Kertesz, J Kertesz
JournalAmerican journal of optometry and physiological optics (Am J Optom Physiol Opt) Vol. 63 Issue 3 Pg. 217-22 (Mar 1986) ISSN: 0093-7002 [Print] United States
PMID3963145 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Accommodation, Ocular
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Convergence, Ocular
  • Esotropia (therapy)
  • Exotropia (therapy)
  • Eye Movements
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Refraction, Ocular
  • Strabismus (diagnosis, therapy)
  • Visual Fields

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: